KR
Kosoor Raju Srinivas
About Kosoor Raju Srinivas
Data last updated:
Kosoor Raju Srinivas is a Director at Skanda Surgicals & Pharma Private Limited (since 2018). The company operates in Pharma. Skanda Surgicals & Pharma Private Limited reported revenue of ₹1.78 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Skanda Surgicals & Pharma Private Limited U74900KA2015PTC082071 | Director | 13 Feb 2018 | 2015 | ₹1.78 Cr (FY 2022) | Active |
Board colleagues of Kosoor Raju Srinivas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandeep Hassan Ramesh | 07188592 | Skanda Surgicals & Pharma Private Limited | Director |
| Shanka Nagesh Ananthalakshmi | 07188581 | Skanda Surgicals & Pharma Private Limited | Director |
| Vinay Prasad Bylahally Jagadeesh | 07200099 | Skanda Surgicals & Pharma Private Limited | Director |
| Yogananda Harihalli Malatesha | 07203778 | Skanda Surgicals & Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kosoor Raju Srinivas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kosoor Raju Srinivas
Kosoor Raju Srinivas currently holds 1 directorship: Skanda Surgicals & Pharma Private Limited (Director, since 13 Feb 2018, revenue ₹1.78 Cr (FY 2022)).
Kosoor Raju Srinivas was first appointed on 13 Feb 2018 as Director at Skanda Surgicals & Pharma Private Limited.
The current boards of Kosoor Raju Srinivas's companies include Sandeep Hassan Ramesh (Skanda Surgicals & Pharma Private Limited), Shanka Nagesh Ananthalakshmi (Skanda Surgicals & Pharma Private Limited), Vinay Prasad Bylahally Jagadeesh (Skanda Surgicals & Pharma Private Limited), Yogananda Harihalli Malatesha (Skanda Surgicals & Pharma Private Limited).